- Home
- BPMC vs HRB Comparison
BPMC vs HRB Comparison
Compare BPMC & HRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- HRB
- Stock Information
- Founded
- BPMC 2008
- HRB 1955
- Country
- BPMC United States
- HRB United States
- Employees
- BPMC N/A
- HRB N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- HRB Other Consumer Services
- Sector
- BPMC Health Care
- HRB Consumer Discretionary
- Exchange
- BPMC Nasdaq
- HRB Nasdaq
- Market Cap
- BPMC 6.7B
- HRB 7.7B
- IPO Year
- BPMC 2015
- HRB N/A
- Fundamental
- Price
- BPMC $111.96
- HRB $54.97
- Analyst Decision
- BPMC Buy
- HRB Sell
- Analyst Count
- BPMC 19
- HRB 2
- Target Price
- BPMC $122.72
- HRB $57.00
- AVG Volume (30 Days)
- BPMC 789.4K
- HRB 1.2M
- Earning Date
- BPMC 02-13-2025
- HRB 02-04-2025
- Dividend Yield
- BPMC N/A
- HRB 2.54%
- EPS Growth
- BPMC N/A
- HRB 13.55
- EPS
- BPMC N/A
- HRB 4.11
- Revenue
- BPMC $434,415,000.00
- HRB $3,620,357,000.00
- Revenue This Year
- BPMC $108.09
- HRB $4.03
- Revenue Next Year
- BPMC $39.34
- HRB $2.61
- P/E Ratio
- BPMC N/A
- HRB $13.34
- Revenue Growth
- BPMC 100.93
- HRB 4.15
- 52 Week Low
- BPMC $72.24
- HRB $42.28
- 52 Week High
- BPMC $121.90
- HRB $68.45
- Technical
- Relative Strength Index (RSI)
- BPMC 71.32
- HRB 49.69
- Support Level
- BPMC $103.67
- HRB $53.09
- Resistance Level
- BPMC $107.88
- HRB $56.00
- Average True Range (ATR)
- BPMC 4.24
- HRB 1.02
- MACD
- BPMC 2.43
- HRB 0.38
- Stochastic Oscillator
- BPMC 97.93
- HRB 77.56
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About HRB H&R Block Inc.
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public primarily in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives most of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively significant.